Biotech shares in the doldrums offer cheaper growth: Ailsa Craig, Investing Show

High-flying biotech shares slumped in the growth sell-off after surging earlier in the Covid pandemic. Does this offer an opportunity to invest in the future of health at a cheaper price. We speak to Ailsa Craig of International Biotechnology Trust.